Ftse Mib
34.806,55
0,91%
DAX
18.676,83
1,05%
S&P 500
5.277,51
0,00%
NASDAQ
16.735,02
0,00%
Bitcoin
69.553,98
2,67%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Precigen Inc (PGEN) Precigen Inc (PGEN) Notizie

Precigen Inc

PGEN
1,43
0,03 (2,14%)
Pre Mercato
Ultimo aggiornamento: 14:59:39
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/6/202401:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:48EDGAR2Form ARS - Annual Report to Security Holders
28/5/202422:44EDGAR2Form DEF 14A - Other definitive proxy statements
23/5/202423:00PRNUSPrecigen to Host a Webcast on June 3rd to Detail Pivotal..
14/5/202423:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202423:19EDGAR2Form 8-K - Current report
14/5/202422:05PRNUSPrecigen Reports First Quarter 2024 Financial Results and..
08/5/202422:05PRNUSPrecigen to Announce First Quarter 2024 Financial Results on..
24/4/202416:20PRNUSPrecigen to Present Late-breaking Abstract for Pivotal Phase..
24/4/202415:00PRNUSActym Therapeutics Appoints Thomas Smart as CEO
28/3/202421:05PRNUSPrecigen and Recurrent Respiratory Papillomatosis Foundation..
19/3/202421:05PRNUSPrecigen Reports Full Year 2023 Financial Results and..
19/3/202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
12/3/202421:05PRNUSPrecigen to Participate in a Fireside Chat Hosted by Cantor..
05/3/202422:05PRNUSPrecigen to Announce Fourth Quarter and Full Year 2023..
27/2/202419:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202421:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:25EDGAR2Form 8-K - Current report
06/2/202422:05PRNUSPrecigen to Participate in the Oppenheimer 34th Annual..
16/1/202414:05PRNUSPrecigen Receives Orphan Drug Designation for PRGN-2012 for..
08/1/202414:39EDGAR2Form 8-K - Current report
08/1/202414:30PRNUSPrecigen Highlights Pipeline Updates to be Presented at the..
29/12/202323:26EDGAR2Form S-3 - Registration statement under Securities Act of..
18/12/202322:05PRNUSPrecigen to Present at the 42nd Annual J.P. Morgan..
29/11/202322:05PRNUSPrecigen to Participate in the JMP Securities Hematology and..
09/11/202323:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:07EDGAR2Form 8-K - Current report
09/11/202322:55PRNUSPrecigen Reports Third Quarter 2023 Financial Results and..
07/11/202322:05PRNUSPrecigen to Participate in the Stifel 2023 Healthcare..
19/9/202322:05PRNUSPrecigen to Participate in Upcoming Leading Investor and..
26/8/202301:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202300:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202301:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202301:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202301:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 1,40

La tua Cronologia

NASDAQ
PGEN
Precigen
LSE
BX02
Tor.dom.29
NASDAQ
CCN
CardConnect Corp.
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network